Company / Interest Expense per Share
Supernus Pharmaceuticals, Inc. Interest Expense per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
-
FY2025
5-year range
$0.00 / $0.37
FY2021-FY2025
Trend
-
vs FY2024
Sector context
#39 of 43
Health Care
What the data says
Improved from $0.02 to $0.00 over the past 2 years.
Health Care sector context is included.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 9% in Health CareTop 9% of 43
▼
Key checks
Key Insights
- Peak interest expense per share was recorded in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.00 | - |
| FY2024 | $0.00 | -100.0% |
| FY2023 | $0.02 | -50.1% |
| FY2022 | $0.05 | -87.2% |
| FY2021 | $0.37 | +0.7% |
| FY2020 | $0.37 | +6.3% |
| FY2019 | $0.35 | +3188.8% |
| FY2018 | $0.01 | -57.0% |
| FY2017 | $0.02 | -75.7% |
| FY2016 | $0.10 | +254.1% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026